Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratorio de Genetica e Diagnostico Molecular, |
RCV003140468 | SCV003807190 | likely pathogenic | Congenital contractural arachnodactyly | 2022-06-17 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PM2 moderated, PM6 moderated, PP3 supporting, PP4 |
Labcorp Genetics |
RCV003140468 | SCV004409940 | uncertain significance | Congenital contractural arachnodactyly | 2022-10-27 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant has not been reported in the literature in individuals affected with FBN2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change falls in intron 30 of the FBN2 gene. It does not directly change the encoded amino acid sequence of the FBN2 protein. |